76770 Federal Register / Vol. 69, No. 245 / Wednesday, December 22, 2004 / Notices 

Status: Portions of the meeting will be 

closed to the public in accordance with 

provisions set forth in Section 552b(c)(4) and 

(6), Title 5 U.S.C., and the Determination of 

the Director, Management Analysis and 

Services Office, CDC, pursuant to Public Law 

92–463. 

Matters To Be Discussed: The meeting will 

include the review, discussion, and 

evaluation of applications received in 

response to: Fetal Alcohol Syndrome 

Prevention and Surveillance in South AfricaDeveloping Community-Level Strategies that 

Work, Request for Applications (RFA) DD05–

011. 

Contact Person for More Information:

JoAnn Thierry, PhD., M.S.W., Scientific 

Review Administrator, Centers for Disease 

Control and Prevention, National Center on 

Birth Defects and Developmental Disabilities, 

1600 Clifton Road NE., Mailstop E88, 

Atlanta, GA 30333, Telephone (404) 498–

3022. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry.

Dated: December 16, 2004. 

Alvin Hall, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention (CDC).

[FR Doc. 04–27953 Filed 12–21–04; 8:45 am] 

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee on Immunization 

Practices: Conference Call Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

Advisory Committee on Immunization 

Practices conference call meeting.

Name: Advisory Committee on 

Immunization Practices. 

Time and Date: 11 a.m.–1 p.m., December 

17, 2004. 

Place: The conference call will originate at 

the National Immunization Program (NIP), in 

Atlanta, Georgia. Please see SUPPLEMENTARY

INFORMATION for details on accessing the 

conference call. 

Status: Open to the public, limited only by 

the availability of telephone ports. 

Purpose: The Committee is charged with 

advising the Director, CDC, on the 

appropriate uses of immunizing agents. In 

addition, under 42 U.S.C. 1396s, the 

committee is mandated to establish and 

periodically review and, as appropriate, 

revise the list of vaccines for administration 

to vaccine-eligible children through the 

Vaccines for Children (VFC) program, along 

with schedules regarding the appropriate 

periodicity, dosage, and contraindications 

applicable to the vaccines. 

Matters To Be Discussed: To discuss both 

the ACIP recommendations and the interim 

Vaccine for Children’s Resolution and as it 

pertains to influenza vaccine priority groups 

this year. 

SUPPLEMENTARY INFORMATION: This 

conference call is scheduled to begin at 11 

a.m., Eastern Standard Time. To participate 

in the conference call, please dial 1–888–

455–0044 and reference passcode 5425415. 

You will then be automatically connected to 

the call. 

As provided under 41 CFR 102–3.150(b), 

the public health urgency of this agency 

business requires that the meeting be held 

prior to the first available date for publication 

of this notice in the Federal Register. 

Contact Person for More Information:

Demetria Gardner, Epidemiology and 

Surveillance Division, National 

Immunization Program, CDC, 1600 Clifton 

Road, NE., (E–61), Atlanta, Georgia 30333, 

telephone 404/639–8096, fax 404/639–8616. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both the CDC and ATSDR.

Dated: December 15, 2004. 

Alvin Hall, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention.

[FR Doc. 04–27922 Filed 12–21–04; 8:45 am] 

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Advisory Research Resources 

Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contact proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Advisory 

Research Resources Council. 

Date: January 19, 2005. 

Open: 8:30 a.m. to 1:55 p.m. 

Agenda: Report of Center Director and 

other issues. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, 6th flr., Conf. 

Rm. 10, Bethesda, MD 20892. 

Closed: 2 p.m. to Adjournment. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, 6th flr., Conf. 

Rm. 10, Bethesda, MD 20892. 

Contact Person: Louise E. Ramm, PhD, 

Deputy Director, National Center for 

Research Resources, National Institutes of 

Health, Building 31, Room 3B11, Bethesda, 

MD 20892, 301–496–6023. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

into the building by non-government 

employees. Persons without a government 

I.D. will need to show a photo I.D. and signin at the security desk upon entering the 

building. 

Information is also available on the 

Institute’s/Center’s home page: http://

www.ncrr.nih.gov/newspub/minutes.htm,

where an agenda and any additional 

information for the meeting will be posted 

when available.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.371, Biomedical 

Technology; 93.389, Research Infrastructure, 

93.306, 93.333, National Institutes of Health, 

HHS)

Dated: December 15, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–27956 Filed 12–21–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice